LGALS3 and Insulin resistance: In an experimental study in gene-modified mice it was shown that Gal-3 can bind directly to the insulin receptor and inhibit downstream insulin receptor signaling, contributing to decreased insulin signaling and insulin resistance and, at the same time, promote adipose tissue inflammation [21].